文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

美国甲型肝炎补种疫苗接种的成本效果:动态传播模型研究

Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
PubMed 文献 · Vaccine · 2021-09-17

本研究采用动态传播模型,评估在美国常规接种基础上对2-18岁未接种儿童和青少年补种甲肝疫苗的公共卫生影响与成本效果。结果显示,与仅常规接种相比,补种策略在100年内可预防70,072例有症状感染、51,391次门诊、16,575次住院和413例死亡,且具有成本节约性。但若对部分接种者追加第二剂,在高接种覆盖率下成本效果不佳。

要点

  • 补种策略预防70,072例有症状感染、51,391次门诊、16,575次住院和413例死亡。
  • 与常规接种相比,补种策略具有成本节约性。
  • 对部分接种者追加第二剂在高覆盖率下成本效果不佳(5%时$196,701/QALY,50%时$476,241/QALY)。

核心结论

  • 美国甲肝补种疫苗接种预期可降低甲肝发病率和死亡率并节约成本。
  • 补种策略应聚焦于未接种儿童和青少年并最大化其首剂覆盖率。

研究设计与样本

  • 使用动态传播模型,比较在常规12-23月龄儿童接种基础上增加2-18岁补种与仅常规接种。
  • 模型包含母体抗体、易感、暴露、无症状感染、有症状感染(门诊、住院、肝移植、移植后、死亡)、康复、接种有免疫力及无免疫力等健康 compartments。
  • 采用3%年贴现率,从社会视角估计每获得一个质量调整生命年(QALY)的增量成本,时间跨度100年,成本转换为2020年美元。

主要发现

  • 与常规12-23月龄接种相比,100年内补种程序额外预防70,072例有症状感染、51,391次门诊就诊、16,575次住院和413例死亡。
  • 补种疫苗接种策略与常规疫苗接种策略相比具有成本节约性。
  • 在允许对部分接种儿童接种第二剂的情景分析中,较高接种覆盖率下成本效果不佳(5%覆盖率时$196,701/QALY,50%覆盖率时$476,241/QALY)。

临床怎么用

  • 在常规儿童甲肝疫苗接种基础上,对2-18岁未接种者实施补种可改善公共卫生并节约成本。
  • 补种应优先覆盖未接种儿童和青少年,并确保其完成首剂接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite routine vaccination of children against hepatitis A (HepA), a large segment of the United States population remains unvaccinated, imposing a risk of hepatitis A virus (HAV) to adolescents and adults. In July of 2020, the Advisory Committee on Immunization Practices recommended that all children and adolescents aged 2-18 years who have not previously received a HepA vaccine be vaccinated. We evaluated the public health impact and cost-effectiveness of this HepA catch-up vaccination strategy. METHODS: We used a dynamic transmission model to compare adding a HepA catch-up vaccination of persons age 2-18 years to a routine vaccination of children 12-23 months of age with routine vaccination only in the United States. The model included various health compartments: maternal antibodies, susceptible, exposed, asymptomatic infectious, symptomatic infectious (outpatient, hospitalized, liver transplant, post- liver transplant, death), recovered, and vaccinated with and without immunity. Using a 3% annual discount rate, we estimated the incremental cost per quality-adjusted life year (QALY) gained from a societal perspective over a 100-year time horizon. All costs were converted into 2020 US dollars. FINDINGS: Compared with the routine vaccination policy at 12-23 months of age over 100 years, the catch-up program for unvaccinated children and adolescents aged 2-18 years, prevented 70,072 additional symptomatic infections, 51,391 outpatient visits, 16,575 hospitalizations, and 413 deaths. The catch-up vaccination strategy was cost-saving when compared with the routine vaccination strategy. In scenario analysis allowing administering a second dose to partially vaccinated children, the cost-effectiveness of was not favorable at a higher vaccination coverage ($196,701/QALY at 5% and $476,241/QALY at 50%). INTERPRETATION: HepA catch-up vaccination in the United States is expected to reduce HepA morbidity and mortality and save cost. The catch-up program would be optimized when focusing on unvaccinated children and adolescents and maximizing their first dose coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Elbasha EH, Choi Y, Daniels V, et al. Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study. Vaccine. 2021. PMID: 34538694. doi:10.1016/j.vaccine.2021.08.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。